Home The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
Article
Licensed
Unlicensed Requires Authentication

The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development

  • Mona Hafez , Soha M. Abd El Dayem EMAIL logo , Fatma El Mougy , Abeer Atef , Manal Kandil , Ashraf Galal and Alaa Abd Al hamid
Published/Copyright: May 22, 2014
Journal of Pediatric Endocrinology and Metabolism
From the journal Journal of Pediatric Endocrinology and Metabolism Volume 27 Issue 9-10

Abstract

Objective: To assess the sensitivity and specificity of anti-Mullerian hormone (AMH) and inhibin B for diagnosis of 46,XY disorders of sex development (DSD).

Patients and methods: The study included 43 patients of 46,XY DSD and compared them with 43 healthy, male, age matched controls. All patients underwent karyotyping, assessment of testosterone, dihydrotestosterone (DHT) and Δ4-androstendione (Δ4A) basal and after human chorionic gonadotropin (HCG) testing. Basal dehydroepiandrosterone (DHEA) was measured. Ultrasonograghy was also done and some cases underwent laparoscopy or gonadal biopsies. Basal AMH and inhibin B were measured in both cases and controls.

Results: The mean age of patients was 5.16±4.24 years. There were significant correlations between basal AMH and HCG stimulated testosterone and DHT (r=0.64; p<0.001 and r=0.52; p<0.001, respectively). Also, significant positive correlations were found between inhibin B and HCG as well as stimulated testosterone and DHT (r=0.62; p<0.001 and r=0.44; p=0.003, respectively). A highly significant correlation was found between AMH and inhibin B (r=0.78; p<0.001). The sensitivity of AMH was (96.6%), specificity (60.7%), NPV (89.5%) and PPV (83.6%). Best cut-off value was (27.11 IU/mL) while overall accuracy was (85%). The sensitivity of inhibin B was (96.6%), specificity (67.9%), NPV (90.5%), PPV (86.2%), and best cut-off value was (41.9 IU/mL) with an overall accuracy (87%).

Conclusion: AMH and inhibin B are valuable, and reliable noninvasive parameters for the detection of functioning testicular tissues in prepubertal patients.

Keywords: 46,XY DSD; anti-Mullerian hormone (AMH); inhibin B; testosterone
Corresponding author: Soha M. Abd El Dayem, Professor of Pediatrics, Consultant of diabetes and Endocrinology, Pediatrics Department, Medical Research Division, National Research Centre, Cairo, Egypt, Phone: +2 01006716852, E-mail:

References

1. Hersmus R, Stoop H, White SJ, Drop SL, Oosterhuis JW, et al. Delayed recognition of disorders of sex development (DSD): a missed opportunity for early diagnosis of malignant germ cell tumors. Int J Endocrinol 2012; Article ID 671209, doi:10.1155/2012/671209.10.1155/2012/671209Search in Google Scholar PubMed PubMed Central

2. Pelayo BF, Carabano AI, Sanz SF, Laorden IE. Ambiguous genitalia. Rev Pediatr Aten Primaria 2011;13:419–33.10.4321/S1139-76322011000300009Search in Google Scholar

3. Mendonca BB, Domenice S, Arnhold IJ, Costa EM. 46, XY disorders of sex development (DSD). Clin Endocrinol (Oxf) 2009;70:173–87.Search in Google Scholar

4. Rey R. How to evaluate gonadal function in the cryptorchid boy; Lessons from new testicular markers. J Pediatr Endocrinol Metab 2003;16:357–64.10.1515/JPEM.2003.16.3.357Search in Google Scholar

5. Huang S, Tou J. Comment on “Serum AMH concentration as a marker evaluating gonadal function in boys operated on for unilateral cryptorchidism between 1st and 4th year of life”. Endocrine 2012;41:544–5.10.1007/s12020-012-9601-7Search in Google Scholar PubMed

6. Aksglaede L, Sørensen K, Boas M, Mouritsen A, Hagen CP, et al. Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 2010;95:5357–64.10.1210/jc.2010-1207Search in Google Scholar PubMed

7. Grinspon RP, Loreti N, Braslavsky D, Bedecarrás P, Ambao V, et al. Sertoli cell markers in the diagnosis of paediatric male hypogonadism. J Pediatr Endocrinol Metab 2012;25:3–11.10.1515/jpem-2011-0453Search in Google Scholar PubMed

8. Adamopoulos DA, Koukkou EG. Value of FSH and inhibin-B measurements in the diagnosis of azoospermia – A clinician’s overview. Int J Androl 2010;33:109–113.10.1111/j.1365-2605.2009.00980.xSearch in Google Scholar PubMed

9. Ahmed SF, Achermann JC, Arlt W, Balen A, Conway G, et al. UK Guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development. Clin Endocrinol (Oxf) 2011;75:12–26.10.1111/j.1365-2265.2011.04076.xSearch in Google Scholar PubMed PubMed Central

10. Cinaz P, Yeşilkaya E, Onganlar YH, Boyraz M, Bideci A, et al. Penile anthropometry of normal prepubertal boys in Turkey. Acta Paediatr 2012;101:33–6.10.1111/j.1651-2227.2011.02386.xSearch in Google Scholar PubMed

11. Zorc JJ, Alpern ER, Brown LW, Loomes KM, Marino BS, et al. Schwartz’s Clinical handbook of pediatrics. 2012;148–153.Search in Google Scholar

12. Grinspon RP, Rey RA. New perspectives in the diagnosis of pediatric male hypogonadism: the importance of AMH as a Sertoli cell marker. Arq Bras Endocrinol Metabol 2011;55: 512–19.10.1590/S0004-27302011000800003Search in Google Scholar PubMed

13. La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon N. Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod 2009;24:2264–75.10.1093/humrep/dep210Search in Google Scholar PubMed

14. Crofton PM, Evans AE, Groome NP, Taylor MR, Holland CV, et al. Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin Endocrinol (Oxf) 2002;56:215–21.10.1046/j.0300-0664.2001.01448.xSearch in Google Scholar PubMed

15. Ohnuma K, Kaneko H, Noguchi J, Kikuchi K, Ozawa M, et al. Production of inhibin A and inhibin B in boars: changes in testicular and circulating levels of dimeric inhibins and characterization of inhibin forms during testis growth. Domest Anim Endocrinol 2007;33:410–21.10.1016/j.domaniend.2006.08.004Search in Google Scholar PubMed

16. Lee PA, Gollenberg AL, Hediger ML, Himes JH, Zhang Z, et al. Luteinizing hormone, testosterone and inhibin B levels in the peripubertal period and racial/ethnic differences among boys aged 6–11 years: analyses from NHANES III, 1988–1994. Clin Endocrinol (Oxf) 2010;73:744–51.10.1111/j.1365-2265.2010.03866.xSearch in Google Scholar PubMed PubMed Central

17. Szarras-Czapnik M, Gajewska M, Ksiazyk J, Janas R, Ginalska-Malinowska M. Anti-Müllerian hormone (AMH) measurements in the assessment of testicular function in prepubertal boys and in sexual differentiation disorders. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2006;12:195–199.Search in Google Scholar

18. Kubini K, Zachmann M, Albers N, Hiort O, Bettendorf M, et al. Basal Inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. J Clin Endocrinol Metab 2000;85:134–8.10.1210/jc.85.1.134Search in Google Scholar

19. Thorup J, Petersen BL, Kvist K, Cortes D. Bilateral vanished testes diagnosed with a single blood sample showing very high gonadotropins (follicle-stimulating hormone and luteinizing hormone) and very low inhibin B. Scand J Urol Nephrol 2011;45:425–31.10.3109/00365599.2011.609833Search in Google Scholar PubMed

20. Brauner R, Neve M, Allali S, Trivin C, Lottmann H, et al. Clinical, biological and genetic analysis of anorchia in 26 boys. PLoS One 2011;6:23292. doi:10.1371/journal.pone.0023292.10.1371/journal.pone.0023292Search in Google Scholar PubMed PubMed Central

21. Gaudino R, Cavarzere P, Camilot M, Teofoli F, Zampieri N, et al. Prepubertal serum inhibin B in cryptorchid infants and in monorchid boys with compensatory testicular hypertrophy. Fertil Steril 2008;90:2217–21.10.1016/j.fertnstert.2007.10.017Search in Google Scholar PubMed

22. Lahlou N, Roger M. Inhibin B in pubertal development and pubertal disorders. Semin Reprod Med 2004;22:165–175.10.1055/s-2004-831892Search in Google Scholar PubMed

23. Adan L, Lechevalier P, Couto-Silva AC, Boissan M, Trivin C, et al. Plasma inhibin B and antimüllerian hormone concentrations in boys: discriminating between congenital hypogonadotropic hypogonadism and constitutional pubertal delay. Med Sci Monit 2010;16:511–17.Search in Google Scholar

24. Lee MM, Donahoe PK, Silverman BL, Hasegawa T, Hasegawa Y, et al. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med 1997;336:1480–86.10.1056/NEJM199705223362102Search in Google Scholar PubMed

25. Misra M, MacLaughlin DT, Donahoe PK, Lee MM. The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization. J Clin Endocrinol Metab 2003;88:787–92.10.1210/jc.2002-020889Search in Google Scholar PubMed

26. Coutant R, Biette-Demeneix E, Bouvattier C, Bouhours-Nouet N, Gatelais F, et al. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J Clin Endocrinol Metab 2010;95:5225–32.10.1210/jc.2010-1535Search in Google Scholar PubMed

27. Nagata Y, Fujita K, Banzai J, Kojima Y, Kasima K, et al. Seminal plasma inhibin-B level is a useful predictor of the success of conventional testicular sperm extraction in patients with non-obstructive azoospermia. J Obstet Gynaecol Res 2005;31:384–8.10.1111/j.1447-0756.2005.00306.xSearch in Google Scholar PubMed

28. Goulis DG, Polychronou P, Mikos T, Grimbizis G, Gerou S, et al. Serum inhibin-B and follicle stimulating hormone as predictors of the presence of sperm in testicular fine needle aspirate in men with azoospermia. Hormones (Athens) 2008;7:140–7.10.1007/BF03401505Search in Google Scholar PubMed

29. Misra M, MacLaughlin DT, Donahoe PK, Lee MM. Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism. J Clin Endocrinol Metab 2002;87:3598–3602.10.1210/jcem.87.8.8742Search in Google Scholar PubMed

Received: 2013-8-31
Accepted: 2014-4-17
Published Online: 2014-5-22
Published in Print: 2014-9-20

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
https://doi.org/10.1515/jpem-2013-0355
Keywords for this article
46,XY DSD; anti-Mullerian hormone (AMH); inhibin B; testosterone

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 20.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0355/html
Scroll to top button